John B Rhodes - Net Worth and Insider Trading
John B Rhodes Net Worth
The estimated net worth of John B Rhodes is at least $0 dollars as of 2024-05-27. John B Rhodes is the Director of Tonix Pharmaceuticals Holding Corp and owns about 1 shares of Tonix Pharmaceuticals Holding Corp (TNXP) stock worth over $0. Details can be seen in John B Rhodes's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John B Rhodes has not made any transactions after 2018-06-01 and currently still holds the listed stock(s).
Transaction Summary of John B Rhodes
John B Rhodes Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John B Rhodes owns 2 companies in total, including Tonix Pharmaceuticals Holding Corp (TNXP) , and Dewey Electronics Corp (DEWY) .
Click here to see the complete history of John B Rhodes’s form 4 insider trades.
Insider Ownership Summary of John B Rhodes
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
TNXP | Tonix Pharmaceuticals Holding Corp | 2018-06-01 | director |
DEWY | Dewey Electronics Corp | 2005-12-07 | director |
John B Rhodes Latest Holdings Summary
John B Rhodes currently owns a total of 1 stock. John B Rhodes owns 1 shares of Tonix Pharmaceuticals Holding Corp (TNXP) as of June 1, 2018, with a value of $0.
Latest Holdings of John B Rhodes
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
TNXP | Tonix Pharmaceuticals Holding Corp | 2018-06-01 | 1 | 0.18 | 0 |
Holding Weightings of John B Rhodes
John B Rhodes Form 4 Trading Tracker
According to the SEC Form 4 filings, John B Rhodes has made a total of 0 transactions in Tonix Pharmaceuticals Holding Corp (TNXP) over the past 5 years. The most-recent trade in Tonix Pharmaceuticals Holding Corp is the acquisition of 0 shares on June 1, 2018, which cost John B Rhodes around $24,975.
Insider Trading History of John B Rhodes
- 1
John B Rhodes Trading Performance
GuruFocus tracks the stock performance after each of John B Rhodes's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John B Rhodes is -50.39%. GuruFocus also compares John B Rhodes's trading performance to market benchmark return within the same time period. The performance of stocks bought by John B Rhodes within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John B Rhodes's insider trading performs compared to the benchmark.
Performance of John B Rhodes
John B Rhodes Ownership Network
Ownership Network List of John B Rhodes
Ownership Network Relation of John B Rhodes
John B Rhodes Owned Company Details
What does Tonix Pharmaceuticals Holding Corp do?
Who are the key executives at Tonix Pharmaceuticals Holding Corp?
John B Rhodes is the director of Tonix Pharmaceuticals Holding Corp. Other key executives at Tonix Pharmaceuticals Holding Corp include director & 10 percent owner & Chief Executive Officer Seth Lederman , Chief Medical Officer Gregory M Sullivan , and Chief Administrative Officer Jessica Edgar Morris .
Tonix Pharmaceuticals Holding Corp (TNXP) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Tonix Pharmaceuticals Holding Corp (TNXP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Tonix Pharmaceuticals Holding Corp (TNXP)'s detailed insider trading history can be found in Insider Trading Tracker table.
Tonix Pharmaceuticals Holding Corp Insider Transactions
John B Rhodes Mailing Address
Above is the net worth, insider trading, and ownership report for John B Rhodes. You might contact John B Rhodes via mailing address: 74 Fifth Avenue, New York Ny 10011.